Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 ...

Biomodal reports methylation sequencing is expanding the window for early detection.

The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.

The GCC Countries Digital Health Market is poised for healthy double-digit growth by 2027, driven by favorable funding for ...

2025年6月27-28日，由美国华人生物医药科技协会中国分会（CBA-China）主办的CBA-China中国年会在苏州国际博览中心圆满落幕。本次盛会以“立足全球视野，聚焦产业前沿”为主题，围绕全球监管动态革新、药物研发策略优化、国际化市场布局等核 ...

A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for ...

A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately assess and predict therapeutic outcomes in lymphoma patients ...

Broader macroeconomic uncertainty has resulted in continued cautiousness for both investors and acquirers in the in vitro ...

The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible ...

A blood test taken in the first trimester could identify women at risk of preeclampsia months before clinical signs emerge, ...

A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy ...